{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:40:34Z","timestamp":1788972034635,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T00:00:00Z","timestamp":1675468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["101656"],"award-info":[{"award-number":["101656"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["101656"],"award-info":[{"award-number":["101656"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["101656"],"award-info":[{"award-number":["101656"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","award":["101656"],"award-info":[{"award-number":["101656"]}],"id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1160379"],"award-info":[{"award-number":["1160379"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083548"],"award-info":[{"award-number":["1083548"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1160379"],"award-info":[{"award-number":["1160379"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083548"],"award-info":[{"award-number":["1083548"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1160379"],"award-info":[{"award-number":["1160379"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083548"],"award-info":[{"award-number":["1083548"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1174091"],"award-info":[{"award-number":["1174091"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1160379"],"award-info":[{"award-number":["1160379"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1083548"],"award-info":[{"award-number":["1083548"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Snow Foundation"},{"DOI":"10.13039\/501100001772","name":"University of New England","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001772","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We have developed a candidate vaccine to protect against multiple strains of <jats:italic>Streptococcus pyogenes<\/jats:italic> infections. The candidate vaccine contains two synthetic peptides derived from <jats:italic>S. pyogenes<\/jats:italic> proteins: the M-protein epitope, p*17 and the IL-8 degrading <jats:italic>S. pyogenes<\/jats:italic> Cell-Envelope Proteinase (SpyCEP) epitope, K4S2. In this study we utilise a rat autoimmune valvulitis model that displays both the cardiac and neurobehavioural pathology associated with post-streptococcal sequelae, to assess if the vaccine candidate antigens induce autoimmune complications and inflammatory pathology. Each antigen was conjugated to carrier protein diphtheria toxoid (DT) and independently assessed for potential to induce autoimmune pathology in female Lewis rats. Rats were administered three subcutaneous doses, and one intranasal dose over a four-week study with a two-week recovery period. A positive control group received recombinant <jats:italic>S. pyogenes<\/jats:italic> M5 (rM5) protein, and the negative control group received PBS. Rats that received rM5 developed significant cardiac and neurological pathologies. There was no evidence of these pathologies in the PBS control group, or the rats administered either P*17-DT or K4S2-DT. This study provides further preclinical evidence of the safety of the vaccine candidates p*17 and K4S2 and their appropriateness as candidates in human clinical trials.<\/jats:p>","DOI":"10.1038\/s41541-023-00604-2","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T13:03:24Z","timestamp":1675515804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Streptococcus pyogenes vaccine candidates do not induce autoimmune responses in a rheumatic heart disease model"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-2003","authenticated-orcid":false,"given":"Simone","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7190-9666","authenticated-orcid":false,"given":"Rukshan Ahamed Mohamed","family":"Rafeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1371-7313","authenticated-orcid":false,"given":"Ailin","family":"Lepletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4151-699X","authenticated-orcid":false,"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4870-706X","authenticated-orcid":false,"given":"Natkunam","family":"Ketheesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-248X","authenticated-orcid":false,"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,4]]},"reference":[{"key":"604_CR1","unstructured":"World Health Organization. World Health Report 164\u2013169 (Office of Publications, World Health Organization, 2000)."},{"key":"604_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis, J. R., Steer, A. C., Mulholland, E. K. & Weber, M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5, 685\u2013694 (2005).","journal-title":"Lancet Infect. Dis."},{"key":"604_CR3","unstructured":"Australian Institute of Health & Welfare. Acute Rheumatic Fever and Rheumatic Heart Disease in Australia 2014\u20132018 (Australia, 2020)."},{"key":"604_CR4","doi-asserted-by":"publisher","unstructured":"Ozberk, V. et al. Prime-pull immunization with a bivalent M-protein and Spy-CEP peptide vaccine adjuvanted with CAF(R)01 liposomes induces both mucosal and peripheral protection from covR\/S mutant. Streptococcus pyogenes. mBio 12, https:\/\/doi.org\/10.1128\/mBio.03537-20 (2021).","DOI":"10.1128\/mBio.03537-20"},{"key":"604_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80508-6","volume":"11","author":"S Reynolds","year":"2021","unstructured":"Reynolds, S. et al. Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines. Sci. Rep. 11, 127 (2021).","journal-title":"Sci. Rep."},{"key":"604_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1365-2567.1996.d01-754.x","volume":"89","author":"ER Brandt","year":"1996","unstructured":"Brandt, E. R. et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 89, 331\u2013337 (1996).","journal-title":"Immunology"},{"key":"604_CR7","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/intimm\/6.8.1235","volume":"6","author":"S Pruksakorn","year":"1994","unstructured":"Pruksakorn, S. et al. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int. Immunol. 6, 1235\u20131244 (1994).","journal-title":"Int. Immunol."},{"key":"604_CR8","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.4049\/jimmunol.149.8.2729","volume":"149","author":"S Pruksakorn","year":"1992","unstructured":"Pruksakorn, S., Galbraith, A., Houghten, R. A. & Good, M. F. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J. Immunol. 149, 2729\u20132735 (1992).","journal-title":"J. Immunol."},{"key":"604_CR9","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0264-410X(97)00178-3","volume":"15","author":"ER Brandt","year":"1997","unstructured":"Brandt, E. R., Hayman, W. A., Currie, B., Pruksakorn, S. & Good, M. F. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci. Vaccine 15, 1805\u20131812 (1997).","journal-title":"Vaccine"},{"key":"604_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","volume":"344","author":"S Pruksakorn","year":"1994","unstructured":"Pruksakorn, S. et al. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 344, 639\u2013642 (1994).","journal-title":"Lancet"},{"key":"604_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ame2.12164","volume":"4","author":"RAM Rafeek","year":"2021","unstructured":"Rafeek, R. A. M. et al. Group A streptococcal antigen exposed rat model to investigate neurobehavioral and cardiac complications associated with post-streptococcal autoimmune sequelae. Anim. Model Exp. Med. 4, 151\u2013161 (2021).","journal-title":"Anim. Model Exp. Med."},{"key":"604_CR12","doi-asserted-by":"publisher","first-page":"675339","DOI":"10.3389\/fcvm.2021.675339","volume":"8","author":"RAM Rafeek","year":"2021","unstructured":"Rafeek, R. A. M. et al. Requirements for a robust animal model to investigate the disease mechanism of autoimmune complications associated with ARF\/RHD. Front Cardiovasc Med. 8, 675339 (2021).","journal-title":"Front Cardiovasc Med."},{"key":"604_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/08916934.2016.1217999","volume":"49","author":"D Gorton","year":"2016","unstructured":"Gorton, D. et al. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease. Autoimmunity 49, 563\u2013570 (2016).","journal-title":"Autoimmunity"},{"key":"604_CR14","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/infdis\/jix637","volume":"218","author":"S Sikder","year":"2018","unstructured":"Sikder, S. et al. Group G streptococcus induces an autoimmune carditis mediated by interleukin 17\u2009A and interferon gamma in the Lewis rat model of rheumatic heart disease. J. Infect. Dis. 218, 324\u2013335 (2018).","journal-title":"J. Infect. Dis."},{"key":"604_CR15","doi-asserted-by":"publisher","unstructured":"Cunningham, M. W. Molecular mimicry, autoimmunity, and infection: the cross-reactive antigens of group A streptococci and their sequelae. Microbiol. Spectr. 7, https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0045-2018 (2019).","DOI":"10.1128\/microbiolspec.GPP3-0045-2018"},{"key":"604_CR16","doi-asserted-by":"publisher","first-page":"102740","DOI":"10.1016\/j.autrev.2020.102740","volume":"20","author":"LM Dooley","year":"2021","unstructured":"Dooley, L. M., Ahmad, T. B., Pandey, M., Good, M. F. & Kotiw, M. Rheumatic heart disease: a review of the current status of global research activity. Autoimmun. Rev. 20, 102740 (2021).","journal-title":"Autoimmun. Rev."},{"key":"604_CR17","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/npp.2012.56","volume":"37","author":"L Brimberg","year":"2012","unstructured":"Brimberg, L. et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 37, 2076\u20132087 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"604_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bbi.2014.02.009","volume":"38","author":"D Lotan","year":"2014","unstructured":"Lotan, D. et al. Behavioral and neural effects of intra-striatal infusion of anti-streptococcal antibodies in rats. Brain, Behav., Immun. 38, 249\u2013262 (2014).","journal-title":"Brain, Behav., Immun."},{"key":"604_CR19","unstructured":"Sika-Paotonu, D., Beaton, A., Raghu, A., Steer, A. & Carapetis, J. in Streptococcus pyogenes: Basic Biology to Clinical Manifestations (eds Ferretti, J. J., Stevens, D. L. & Fischetti, V. A.) (2016)."},{"key":"604_CR20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3892\/etm.2020.9526","volume":"21","author":"D Dop","year":"2021","unstructured":"Dop, D., Marcu, I. R., Padureanu, R., Niculescu, C. E. & Padureanu, V. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (Review). Exp. Ther. Med. 21, 94 (2021).","journal-title":"Exp. Ther. Med."},{"key":"604_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/apha.12614","volume":"216","author":"MW Cunningham","year":"2016","unstructured":"Cunningham, M. W. & Cox, C. J. Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond. Acta Physiol. 216, 90\u2013100 (2016).","journal-title":"Acta Physiol."},{"key":"604_CR22","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1080\/21645515.2016.1222999","volume":"12","author":"MR Batzloff","year":"2016","unstructured":"Batzloff, M. R. et al. Preclinical immunogenicity and safety of a Group A streptococcal M protein-based vaccine candidate. Hum. Vaccin Immunother. 12, 3089\u20133096 (2016).","journal-title":"Hum. Vaccin Immunother."},{"key":"604_CR23","doi-asserted-by":"publisher","first-page":"e0156639","DOI":"10.1371\/journal.pone.0156639","volume":"11","author":"C McNeilly","year":"2016","unstructured":"McNeilly, C. et al. Predicted coverage and immuno-safety of a recombinant C-repeat region based Streptococcus pyogenes vaccine candidate. PLoS ONE 11, e0156639 (2016).","journal-title":"PLoS ONE"},{"key":"604_CR24","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.4049\/jimmunol.1700836","volume":"199","author":"T Nordstrom","year":"2017","unstructured":"Nordstrom, T. et al. Enhancing vaccine efficacy by engineering a complex synthetic peptide to become a super immunogen. J. Immunol. 199, 2794\u20132802 (2017).","journal-title":"J. Immunol."},{"key":"604_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1084\/jem.20132126","volume":"211","author":"L Wu","year":"2014","unstructured":"Wu, L. et al. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 211, 1449\u20131464 (2014).","journal-title":"J. Exp. Med."},{"key":"604_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/eji.200839090","volume":"39","author":"AM Cooper","year":"2009","unstructured":"Cooper, A. M. IL-17 and anti-bacterial immunity: protection versus tissue damage. Eur. J. Immunol. 39, 649\u2013652 (2009).","journal-title":"Eur. J. Immunol."},{"key":"604_CR27","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/08916934.2019.1605356","volume":"52","author":"S Sikder","year":"2019","unstructured":"Sikder, S. et al. Group A streptococcal M-protein specific antibodies and T-cells drive the pathology observed in the rat autoimmune valvulitis model. Autoimmunity 52, 78\u201387 (2019).","journal-title":"Autoimmunity"},{"key":"604_CR28","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.4049\/jimmunol.1501994","volume":"196","author":"M Pandey","year":"2016","unstructured":"Pandey, M. et al. Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR\/S mutant streptococci. J. Immunol. 196, 3364\u20133374 (2016).","journal-title":"J. Immunol."},{"key":"604_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14157-7","volume":"7","author":"M Pandey","year":"2017","unstructured":"Pandey, M. et al. Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial. Sci. Rep. 7, 13786 (2017).","journal-title":"Sci. Rep."},{"key":"604_CR30","doi-asserted-by":"publisher","first-page":"E291","DOI":"10.1016\/S2666-5247(20)30240-8","volume":"2","author":"J Osowicki","year":"2021","unstructured":"Osowicki, J. et al. A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-75): an observational, dose-finding study. Lancet Microbe 2, E291\u2013E299 (2021).","journal-title":"Lancet Microbe"},{"key":"604_CR31","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/374800","volume":"187","author":"MR Batzloff","year":"2003","unstructured":"Batzloff, M. R. et al. Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J. Infect. Dis. 187, 1598\u20131608 (2003).","journal-title":"J. Infect. Dis."},{"key":"604_CR32","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1128\/IAI.01514-08","volume":"77","author":"D Gorton","year":"2009","unstructured":"Gorton, D., Govan, B., Olive, C. & Ketheesan, N. B- and T-cell responses in group a streptococcus M-protein- or peptide-induced experimental carditis. Infect. Immun. 77, 2177\u20132183 (2009).","journal-title":"Infect. Immun."},{"key":"604_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jim.2010.02.013","volume":"355","author":"D Gorton","year":"2010","unstructured":"Gorton, D., Blyth, S., Gorton, J. G., Govan, B. & Ketheesan, N. An alternative technique for the induction of autoimmune valvulitis in a rat model of rheumatic heart disease. J. Immunol. Methods 355, 80\u201385 (2010).","journal-title":"J. Immunol. Methods"},{"key":"604_CR34","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1128\/IAI.69.6.4072-4078.2001","volume":"69","author":"A Quinn","year":"2001","unstructured":"Quinn, A., Kosanke, S., Fischetti, V. A., Factor, S. M. & Cunningham, M. W. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect. Immun. 69, 4072\u20134078 (2001).","journal-title":"Infect. Immun."},{"key":"604_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0896-8411(03)00026-X","volume":"20","author":"RS Lymbury","year":"2003","unstructured":"Lymbury, R. S. et al. Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J. Autoimmun. 20, 211\u2013217 (2003).","journal-title":"J. Autoimmun."},{"key":"604_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12571","author":"RA Rafeek","year":"2022","unstructured":"Rafeek, R. A. et al. Characterization of an experimental model to determine streptococcal M protein-induced autoimmune cardiac and neurobehavioral abnormalities. Immunol. Cell Biol. https:\/\/doi.org\/10.1111\/imcb.12571 (2022).","journal-title":"Immunol. Cell Biol."},{"key":"604_CR37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1037\/0735-7044.97.5.697","volume":"97","author":"B Kolb","year":"1983","unstructured":"Kolb, B. & Holmes, C. Neonatal motor cortex lesions in the rat: absence of sparing of motor behaviors and impaired spatial learning concurrent with abnormal cerebral morphogenesis. Behav. Neurosci. 97, 697 (1983).","journal-title":"Behav. Neurosci."},{"key":"604_CR38","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.neuroscience.2006.10.038","volume":"144","author":"S Urakawa","year":"2007","unstructured":"Urakawa, S. et al. Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats. Neuroscience 144, 920\u2013933 (2007).","journal-title":"Neuroscience"},{"key":"604_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0896-6273(01)00564-5","volume":"33","author":"JM Greer","year":"2002","unstructured":"Greer, J. M. & Capecchi, M. R. Hoxb8 is required for normal grooming behavior in mice. Neuron 33, 23\u201334 (2002).","journal-title":"Neuron"}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00604-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00604-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T13:05:02Z","timestamp":1675515902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-023-00604-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,4]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1038\/s41541-023-00604-2","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,4]]},"assertion":[{"value":"1 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}